A61P 17/12
Keratolytics
Official title: Keratolytics, e.g. wart or anti-corn preparations
A61P17/12 (Keratolytics) appears on 884 US grants and 1,396 published applications in this corpus.
Search patents in A61P- Granted patents
- 884
- Published applications
- 1,396
- Assignees
- 571
- Inventors
- 1,968
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 12 | 0 |
| 1999 | 10 | 0 |
| 2000 | 16 | 0 |
| 2001 | 21 | 5 |
| 2002 | 25 | 23 |
| 2003 | 24 | 52 |
| 2004 | 21 | 64 |
| 2005 | 13 | 50 |
| 2006 | 23 | 54 |
| 2007 | 23 | 62 |
| 2008 | 20 | 94 |
| 2009 | 34 | 76 |
| 2010 | 49 | 136 |
| 2011 | 67 | 99 |
| 2012 | 52 | 98 |
| 2013 | 59 | 62 |
| 2014 | 50 | 87 |
| 2015 | 51 | 62 |
| 2016 | 50 | 54 |
| 2017 | 50 | 56 |
| 2018 | 41 | 63 |
| 2019 | 45 | 41 |
| 2020 | 34 | 38 |
| 2021 | 32 | 34 |
| 2022 | 15 | 27 |
| 2023 | 17 | 16 |
| 2024 | 8 | 12 |
| 2025 | 12 | 20 |
| 2026 | 4 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cosmetic compositions for skin health and methods of using same11 Aug 2026US 12,702,638 B2Locus Solutions Ipco, LLC
- Compositions for pathogenesis-directed therapy and treatments of skin diseases and disorders26 May 2026US 12,636,273 B2Yale University
- Peptide-containing composition for use for treating neoplastic lesions14 Apr 2026US 12,599,646 B2Cytovation Asa
- FC variants7 Apr 2026US 12,595,299 B2Chugai Seiyaku Kabushiki Kaisha
- EGFR inhibitors for treating keratodermas9 Dec 2025US 12,491,186 B2Assistance Publique-HôPitaux De Paris (Aphp)
- Compositions for pathogenesis-directed therapy and treatments of skin diseases and disorders3 Sep 2026US 2026/0256737 A1Yale University
- Compositions comprising melatonin, 5-fluorouracil and dimethyl sulfoxide for use in the treatment of actinic keratosis3 Sep 2026US 2026/0256788 A1RepoCeuticals A/S
- Cosmetic or dermatological composition comprising polylysine dendrimers and use thereof20 Aug 2026US 2026/0240751 A1
- Compositions suitable for use on sensitive skin and methods using same13 Aug 2026US 2026/0232551 A1Kenvue Brands LLC
- Egfr inhibitors for treating keratodermas13 Aug 2026US 2026/0232667 A1Assistance Publique-HôPitaux De Paris (Aphp)
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Modified antibody variable domains462US 5,766,886 AXoma Corporation · 1998
- Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents342US 6,309,663 B1Lipocine Inc. · 2001